Treatments and outcomes for patients with spinal muscular atrophy (SMA) type 2: Findings from RESTORE registry

被引：0
|
作者：
Servais, L. [1 ]
Benguerba, K. [2 ]
De Vivo, D. [3 ]
Kirschner, J. [4 ]
Muntoni, F. [5 ]
Proud, C. [6 ]
Tizzano, E. [7 ]
Quijano-Roy, S. [8 ]
Desguerre, I. [9 ]
Saito, K. [10 ]
Raju, D. [11 ]
LaMarca, N. [11 ]
Sun, R. [11 ]
Anderson, F. [12 ]
Faulkner, E. [11 ]
Finkel, R. [13 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Novartis Gene Therapies Switzerland GmbH, Rotkreuz, Switzerland
[3] Columbia Univ, Irving Med Ctr, New York, NY USA
[4] Univ Med Ctr Freiburg, Freiberg, Germany
[5] UCL, London, England
[6] Childrens Hosp Kings Daughters, Norfolk, VA USA
[7] Hosp Valle De Hebron, Barcelona, Spain
[8] Raymond Poincare Univ Hosp, APHP, Garches, France
[9] Hop Necker Enfants Malad, Paris, France
[10] Tokyo Womens Med Univ, Tokyo, Japan
[11] Novartis Gene Therapies Inc, Bannockburn, IL USA
[12] Univ Massachusetts, Med Sch, Worcester, MA USA
[13] St Jude Childrens Res Hosp, Memphis, TN USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.189
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.104
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [41] The Canadian Neuromuscular Disease Registry: A National Spinal Muscular Atrophy (SMA) Registry for Real World Evidence
    Oskoui, Maryam
    Vajsar, Jiri
    Hodgkinson, Victoria
    Brais, Bernard
    MacKenzie, Alex
    McMillan, Hugh
    Campbell, Craig
    Korngut, Lawrence
    NEUROLOGY, 2020, 94 (15)
  • [42] The Muscular Dystrophy Association (MDA) US Neuromuscular Disease (NMD) Registry: Initial Data on Patients with Spinal Muscular Atrophy (SMA)
    Jones, Cynthia C.
    Eaton, Susan
    Li, Li
    Wang, Nasha
    Cwik, Valerie
    Cook, Suzanne F.
    Gheuens, Sarah
    Dilley, Anne
    NEUROLOGY, 2017, 88
  • [43] Comparing Spinal Muscular Atrophy (SMA) outcomes between a patient-reported membership database and a clinical data registry
    Belter, Lisa
    Whitmire, Sarah
    Curry, Mary
    Schroth, Mary
    NEUROLOGY, 2023, 100 (17)
  • [44] Genetic findings of Cypriot spinal muscular atrophy patients
    Theodorou, L.
    Nicolaou, P.
    Koutsou, P.
    Georghiou, A.
    Anastasiadou, V.
    Tanteles, G.
    Kyriakides, T.
    Zamba-Papanicolaou, E.
    Christodoulou, K.
    NEUROLOGICAL SCIENCES, 2015, 36 (10) : 1829 - 1834
  • [45] Genetic findings of Cypriot spinal muscular atrophy patients
    L. Theodorou
    P. Nicolaou
    P. Koutsou
    A. Georghiou
    V. Anastasiadou
    G. Tanteles
    T. Kyriakides
    E. Zamba-Papanicolaou
    K. Christodoulou
    Neurological Sciences, 2015, 36 : 1829 - 1834
  • [46] Spinal muscular atrophy type 1: Management and outcomes
    Bach, JR
    Baird, JS
    Plosky, D
    Navado, J
    Weaver, B
    PEDIATRIC PULMONOLOGY, 2002, 34 (01) : 16 - 22
  • [47] Tracking bone health in paediatric patients with spinal muscular atrophy (SMA)
    Secgen, N.
    Yildiz, S. Oz
    Aksoy, T.
    Demirkiran, G.
    Ozon, A.
    Yazici, M.
    Aydingoz, U.
    Haliloglu, G.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S89 - S89
  • [48] Real-world outcomes following onasemnogene abeparvovec in patients with SMA and invasive ventilatory support: findings from the RESTORE Registry
    Servais, L.
    Shieh, P.
    Goedeker, N.
    Waldrop, M.
    Bo, R.
    Erbas, Y.
    Raju, D.
    Benguerba, K.
    Reyna, S.
    Wolff, D.
    Finkel, R.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [49] Health Utility index scores in patients with spinal muscular atrophy: findings from the 2019 cure SMA community update survey
    Belter, L.
    Cruz, R.
    Jarecki, J.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S113 - S113
  • [50] Nutritional status of a large cohort of children with spinal muscular atrophy type 2 (SMA2)
    Schottlaender, L.
    Scoto, M.
    Imbrigiotta, N.
    Davis, T.
    Main, M.
    Munot, P.
    Sarkozy, A.
    Manzur, A.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S133 - S133
12345